A new tool against breast cancer: 3D bioprinted tumors using pig tissue
Elisabeth Engel
Group leader
Zaida Álvarez wins the Rafael Hervada prize
At the press conference held this morning at the San Rafael Hospital, the Rafael Hervada prize was announced. Zaida Álvarez, current researcher at IBEC, has been awarded for her pioneering research on regeneration of spinal cord injuries using nanotechnology at the Northwestern University, Chicago, USA.
Biomaterials made at IBEC reach the Bulgarian press
The research carried at the “Biomaterials for regenerative therapies” group at IBEC, has reached the international press. In this case, the magazine Cosmos from Bulgary has published an article explaining their research in biomaterials and the use of nanoparticles.
nAngioDerm participated in world congress TERMIS
Professor Elisabeth Engel from IBEC, coordinator of nAngioDerm European project, presented the advances of the project at the 6th world congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS2021). Professor Engel talked about cells-materials interactions to promote vascularization in one of the most important scientific conferences in the field of tissue engineering and regenerative medicine.
The IBEC Researcher, Zaida Álvarez Awarded the Mike Line Scholarship
The IBEC researcher, Zaida Álvarez, has been awarded the 2nd edition of the Mike Lane Scholarship. Thus, Dr. Álvarez has been awarded, for her research in innovative regenerative therapies, almost €17,000, contributed by more than 75 patrons through a micro-patronage campaign and by the Castellers de la Vila de Gràcia.
Two IBEC projects granted by “Knowledge Industry Call” of the Catalan Government
A project led by Elisabeth Engel aimed to fabricate and test a dressing prototype for wound healing, and another project led by Javier Ramón with the goal of developing an artificial liver, have been granted by the Knowledge Industry Programme of the Catalan Government.
Dermoglass in the media
Elisabeth Engel from the Institute for Bioengineering of Catalonia (IBEC) and Professor at the Polytechnic University of Catalonia (UPC) appears in different media for the Dermoglass technology, the first project financed by the CaixaImpulse program to be licensed to a pharmaceutical company.
Dermoglass technology takes the leap into the pharmaceutical industry
Dermoglass becomes the first project funded by the CaixaImpulse program to be licensed to a pharmaceutical company, Laboratorios ERN. It is a new technology to tackle chronic ulcers developed by the research group “Biomaterials for Regenerative Therapies” led by Dr. Elisabeth Engel at the Institute for Bioengineering of Catalonia (IBEC), who is also Professor at Polytechnic University of Catalonia (UPC).
Two IBEC researchers receive a Beatriu de Pinós fellowship
Aurora Dols and Zaida Álvarez, researchers at the Institute for Bioengineering of Catalonia (IBEC), receive the prestigious fellowships Beatriu de Pinós, awarded by the Catalan Government for the incorporation of highly qualified postdoctoral researchers into the Catalan research system.
3D printed hydrogels for cancer immunotherapy T-cell growth
The new 3D hydrogels provide high rates of cell proliferation, as they mimic lymph nodes, where T-cells reproduce in vivo. A new project, led by researchers from ICMAB and IBEC, and with the collaboration of VHIO and UIC, wants to transfer this technology to hospitals.
Cancer immunotherapy is based on using and strengthening the patient’s own immune system to recognize and fight tumor cells, without damaging healthy tissues.